Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Organochlorine pesticide residues in human breast tissue and their relationships with clinical and pathological characteristics of breast cancer.

Ellsworth RE, Kostyniak PJ, Chi LH, Shriver CD, Costantino NS, Ellsworth DL.

Environ Toxicol. 2018 Jun 19. doi: 10.1002/tox.22573. [Epub ahead of print]

PMID:
29923341
2.

Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer.

Rummel SK, Lovejoy L, Shriver CD, Ellsworth RE.

Breast Cancer Res Treat. 2017 Aug;164(3):593-601. doi: 10.1007/s10549-017-4291-8. Epub 2017 May 13.

PMID:
28503720
3.

Breast Cancer Metastasis to the Axillary Lymph Nodes: Are Changes to the Lymph Node "Soil" Localized or Systemic?

Blackburn HL, Ellsworth DL, Shriver CD, Ellsworth RE.

Breast Cancer (Auckl). 2017 Feb 10;11:1178223417691246. doi: 10.1177/1178223417691246. eCollection 2017.

4.

Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.

Ellsworth DL, Blackburn HL, Shriver CD, Rabizadeh S, Soon-Shiong P, Ellsworth RE.

Clin Transl Med. 2017 Dec;6(1):15. doi: 10.1186/s40169-017-0145-6. Epub 2017 Apr 12. Review.

5.

The role of the histoblood ABO group in cancer.

Rummel SK, Ellsworth RE.

Future Sci OA. 2016 Mar 15;2(2):FSO107. doi: 10.4155/fsoa-2015-0012. eCollection 2016 Jun. Review.

6.

Molecular heterogeneity in breast cancer: State of the science and implications for patient care.

Ellsworth RE, Blackburn HL, Shriver CD, Soon-Shiong P, Ellsworth DL.

Semin Cell Dev Biol. 2017 Apr;64:65-72. doi: 10.1016/j.semcdb.2016.08.025. Epub 2016 Aug 26. Review.

7.

Outcome Disparities in African American Compared with European American Women with ER+HER2- Tumors Treated within an Equal-Access Health Care System.

Costantino NS, Freeman B, Shriver CD, Ellsworth RE.

Ethn Dis. 2016 Jul 21;26(3):407-16. doi: 10.18865/ed.26.3.407.

8.

Effect of obesity on molecular characteristics of invasive breast tumors: gene expression analysis in a large cohort of female patients.

Toro AL, Costantino NS, Shriver CD, Ellsworth DL, Ellsworth RE.

BMC Obes. 2016 Apr 29;3:22. doi: 10.1186/s40608-016-0103-7. eCollection 2016.

9.

Tumour location within the breast: Does tumour site have prognostic ability?

Rummel S, Hueman MT, Costantino N, Shriver CD, Ellsworth RE.

Ecancermedicalscience. 2015 Jul 13;9:552. doi: 10.3332/ecancer.2015.552. eCollection 2015.

10.

Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis.

Ellsworth RE, Toro AL, Blackburn HL, Decewicz A, Deyarmin B, Mamula KA, Costantino NS, Hooke JA, Shriver CD, Ellsworth DL.

Cancer Growth Metastasis. 2015 Jul 20;8:15-24. doi: 10.4137/CGM.S29490. eCollection 2015.

11.

Management of Incidental Findings in the Era of Next-generation Sequencing.

Blackburn HL, Schroeder B, Turner C, Shriver CD, Ellsworth DL, Ellsworth RE.

Curr Genomics. 2015 Jun;16(3):159-74. doi: 10.2174/1389202916666150317232930.

12.

Abundance and distribution of polychlorinated biphenyls (PCBs) in breast tissue.

Ellsworth RE, Mamula KA, Costantino NS, Deyarmin B, Kostyniak PJ, Chi LH, Shriver CD, Ellsworth DL.

Environ Res. 2015 Apr;138:291-7. doi: 10.1016/j.envres.2015.02.025. Epub 2015 Mar 5.

PMID:
25749124
13.

Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancer.

Barrow TM, Barault L, Ellsworth RE, Harris HR, Binder AM, Valente AL, Shriver CD, Michels KB.

Int J Cancer. 2015 Aug 1;137(3):537-47. doi: 10.1002/ijc.29419. Epub 2015 Jan 21.

14.

Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy.

Blackburn HL, Ellsworth DL, Shriver CD, Ellsworth RE.

Cancer Causes Control. 2015 Mar;26(3):319-32. doi: 10.1007/s10552-014-0519-7. Epub 2015 Jan 3. Review.

PMID:
25554091
15.
16.

Sequence-based detection of mutations in cadherin 1 to determine the prevalence of germline mutations in patients with invasive lobular carcinoma of the breast.

Valente AL, Rummel S, Shriver CD, Ellsworth RE.

Hered Cancer Clin Pract. 2014 Jul 19;12(1):17. doi: 10.1186/1897-4287-12-17. eCollection 2014.

17.

Gene expression differences in adipose tissue associated with breast tumorigenesis.

Sturtz LA, Deyarmin B, van Laar R, Yarina W, Shriver CD, Ellsworth RE.

Adipocyte. 2014 Apr 1;3(2):107-14. doi: 10.4161/adip.28250. Epub 2014 Feb 20.

18.

Molecular response of the axillary lymph node microenvironment to metastatic colonization.

Valente AL, Kane JL, Ellsworth DL, Shriver CD, Ellsworth RE.

Clin Exp Metastasis. 2014 Jun;31(5):565-72. doi: 10.1007/s10585-014-9650-9. Epub 2014 Apr 1.

PMID:
24687565
19.

PSPHL and breast cancer in African American women: causative gene or population stratification?

Rummel S, Penatzer CE, Shriver CD, Ellsworth RE.

BMC Genet. 2014 Mar 20;15:38. doi: 10.1186/1471-2156-15-38.

21.

Leukocyte DNA as surrogate for the evaluation of imprinted Loci methylation in mammary tissue DNA.

Barault L, Ellsworth RE, Harris HR, Valente AL, Shriver CD, Michels KB.

PLoS One. 2013;8(2):e55896. doi: 10.1371/journal.pone.0055896. Epub 2013 Feb 7.

22.

Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer.

Rummel S, Varner E, Shriver CD, Ellsworth RE.

Breast Cancer Res Treat. 2013 Jan;137(1):119-25. doi: 10.1007/s10549-012-2348-2. Epub 2012 Nov 29.

PMID:
23192404
23.

Molecular alterations associated with breast cancer mortality.

Voeghtly LM, Mamula K, Campbell JL, Shriver CD, Ellsworth RE.

PLoS One. 2012;7(10):e46814. doi: 10.1371/journal.pone.0046814. Epub 2012 Oct 4.

24.

Genomic (in)stability of the breast tumor microenvironment.

Rummel S, Valente AL, Kane JL, Shriver CD, Ellsworth RE.

Mol Cancer Res. 2012 Dec;10(12):1526-31. doi: 10.1158/1541-7786.MCR-12-0425. Epub 2012 Oct 4.

25.

FH535 inhibited migration and growth of breast cancer cells.

Iida J, Dorchak J, Lehman JR, Clancy R, Luo C, Chen Y, Somiari S, Ellsworth RE, Hu H, Mural RJ, Shriver CD.

PLoS One. 2012;7(9):e44418. doi: 10.1371/journal.pone.0044418. Epub 2012 Sep 11.

26.

Impact of lifestyle factors on prognosis among breast cancer survivors in the USA.

Ellsworth RE, Valente AL, Shriver CD, Bittman B, Ellsworth DL.

Expert Rev Pharmacoecon Outcomes Res. 2012 Aug;12(4):451-64. doi: 10.1586/erp.12.37. Review.

PMID:
22971032
27.

Effect of ASCO/CAP guidelines for determining ER status on molecular subtype.

Deyarmin B, Kane JL, Valente AL, van Laar R, Gallagher C, Shriver CD, Ellsworth RE.

Ann Surg Oncol. 2013 Jan;20(1):87-93. doi: 10.1245/s10434-012-2588-8. Epub 2012 Aug 9.

PMID:
22875649
28.

Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes: a genotype-phenotype correlation study.

Rummel S, Shriver CD, Ellsworth RE.

BMC Med Genet. 2012 May 29;13:41. doi: 10.1186/1471-2350-13-41.

29.

Differential gene expression in primary breast tumors associated with lymph node metastasis.

Ellsworth RE, Field LA, Love B, Kane JL, Hooke JA, Shriver CD.

Int J Breast Cancer. 2011;2011:142763. doi: 10.4061/2011/142763. Epub 2011 May 15.

30.

Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women.

Field LA, Love B, Deyarmin B, Hooke JA, Shriver CD, Ellsworth RE.

Cancer. 2012 Mar 1;118(5):1334-44. doi: 10.1002/cncr.26405. Epub 2011 Jul 28.

31.

Laser microdissection for gene expression profiling.

Field LA, Deyarmin B, Shriver CD, Ellsworth DL, Ellsworth RE.

Methods Mol Biol. 2011;755:17-45. doi: 10.1007/978-1-61779-163-5_2.

PMID:
21761291
32.

Breast axillary lymph node metastasis.

Cavalli LR, Ellsworth RE, Klein C, Viale G.

Int J Breast Cancer. 2011;2011:304697. doi: 10.4061/2011/304697. Epub 2012 Feb 13. No abstract available.

33.

Breast cancer in the personal genomics era.

Ellsworth RE, Decewicz DJ, Shriver CD, Ellsworth DL.

Curr Genomics. 2010 May;11(3):146-61. doi: 10.2174/138920210791110951.

34.

Chromosomal alterations in pure nonneoplastic breast lesions: implications for breast cancer progression.

Ellsworth RE, Ellsworth DL, Weyandt JD, Fantacone-Campbell JL, Deyarmin B, Hooke JA, Shriver CD.

Ann Surg Oncol. 2010 Jun;17(6):1688-94. doi: 10.1245/s10434-010-0910-x. Epub 2010 Jan 27.

PMID:
20107913
35.

Genomic instability in the breast microenvironment? A critical evaluation of the evidence.

Holliday C, Rummel S, Hooke JA, Shriver CD, Ellsworth DL, Ellsworth RE.

Expert Rev Mol Diagn. 2009 Oct;9(7):667-78. doi: 10.1586/erm.09.55. Review.

PMID:
19817552
36.

Molecular changes in primary breast tumors and the Nottingham Histologic Score.

Ellsworth RE, Hooke JA, Love B, Ellsworth DL, Shriver CD.

Pathol Oncol Res. 2009 Dec;15(4):541-7. doi: 10.1007/s12253-009-9151-3. Epub 2009 Feb 5.

PMID:
19194786
37.

Genomic heterogeneity of breast tumor pathogenesis.

Ellsworth RE, Hooke JA, Shriver CD, Ellsworth DL.

Clin Med Oncol. 2009 Jul 29;3:77-85.

38.

A gene expression signature that defines breast cancer metastases.

Ellsworth RE, Seebach J, Field LA, Heckman C, Kane J, Hooke JA, Love B, Shriver CD.

Clin Exp Metastasis. 2009;26(3):205-13. doi: 10.1007/s10585-008-9232-9. Epub 2008 Dec 27.

PMID:
19112599
39.

Environmental chemicals and breast cancer risk--a structural chemistry perspective.

Weyandt J, Ellsworth RE, Hooke JA, Shriver CD, Ellsworth DL.

Curr Med Chem. 2008;15(26):2680-701. Review.

PMID:
18991630
40.

Amplification of HER2 is a marker for global genomic instability.

Ellsworth RE, Ellsworth DL, Patney HL, Deyarmin B, Love B, Hooke JA, Shriver CD.

BMC Cancer. 2008 Oct 14;8:297. doi: 10.1186/1471-2407-8-297.

41.

Chromosomal alterations associated with the transition from in situ to invasive breast cancer.

Ellsworth RE, Vertrees A, Love B, Hooke JA, Ellsworth DL, Shriver CD.

Ann Surg Oncol. 2008 Sep;15(9):2519-25. doi: 10.1245/s10434-008-0051-7. Epub 2008 Jul 12.

PMID:
18622645
42.

Genomic alterations associated with early stages of breast tumor metastasis.

Ellsworth RE, Ellsworth DL, Patney HL, Deyarmin B, Hooke JA, Love B, Shriver CD.

Ann Surg Oncol. 2008 Jul;15(7):1989-95. doi: 10.1245/s10434-008-9902-5. Epub 2008 Apr 10.

PMID:
18401664
43.

The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer.

Becker TE, Ellsworth RE, Deyarmin B, Patney HL, Jordan RM, Hooke JA, Shriver CD, Ellsworth DL.

Ann Surg Oncol. 2008 Apr;15(4):1056-63. doi: 10.1245/s10434-008-9815-3. Epub 2008 Feb 2.

PMID:
18246400
44.

The Clinical Breast Care Project: an important resource in investigating environmental and genetic contributions to breast cancer in African American women.

Ellsworth RE, Zhu K, Bronfman L, Gutchell V, Hooke JA, Shriver CD.

Cell Tissue Bank. 2008 Jun;9(2):109-20. Epub 2007 Oct 11.

PMID:
17929197
45.

Genomic instability and the development of metastatic lymph node tumors.

Callaghan KA, Becker TE, Ellsworth DL, Hooke JA, Ellsworth RE, Shriver CD.

Ann Surg Oncol. 2007 Nov;14(11):3125-32. Epub 2007 Jul 25.

PMID:
17653592
46.

Correlation of levels and patterns of genomic instability with histological grading of DCIS.

Ellsworth RE, Ellsworth DL, Love B, Patney HL, Hoffman LR, Kane J, Hooke JA, Shriver CD.

Ann Surg Oncol. 2007 Nov;14(11):3070-7. Epub 2007 Jun 5.

PMID:
17549568
47.

Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors.

Ellsworth RE, Hooke JA, Love B, Kane JL, Patney HL, Ellsworth DL, Shriver CD.

Breast Cancer Res Treat. 2008 Jan;107(2):259-65. Epub 2007 Mar 10.

PMID:
17351743
48.

Functional identity of genes detectable in expression profiling assays following globin mRNA reduction of peripheral blood samples.

Field LA, Jordan RM, Hadix JA, Dunn MA, Shriver CD, Ellsworth RE, Ellsworth DL.

Clin Biochem. 2007 Apr;40(7):499-502. Epub 2007 Jan 17.

PMID:
17303101
49.

Timing of critical genetic changes in human breast disease.

Ellsworth RE, Ellsworth DL, Deyarmin B, Hoffman LR, Love B, Hooke JA, Shriver CD.

Ann Surg Oncol. 2005 Dec;12(12):1054-60. Epub 2005 Oct 10.

PMID:
16228814
50.

Allelic imbalance in primary breast carcinomas and metastatic tumors of the axillary lymph nodes.

Ellsworth RE, Ellsworth DL, Neatrour DM, Deyarmin B, Lubert SM, Sarachine MJ, Brown P, Hooke JA, Shriver CD.

Mol Cancer Res. 2005 Feb;3(2):71-7.

Supplemental Content

Loading ...
Support Center